Cargando…

Considerations in Understanding Vaccine Effectiveness

Although vaccine effectiveness reports are essential to assessing policies on SARS-CoV-2 vaccination, several factors can affect our interpretation of the results. These include the waning of antibodies, the prevailing viral variants at the time of the study, and COVID-19 disease prevalence in the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Chin Shern, Aw, Tar Choon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864852/
https://www.ncbi.nlm.nih.gov/pubmed/36679865
http://dx.doi.org/10.3390/vaccines11010020
_version_ 1784875687698497536
author Lau, Chin Shern
Aw, Tar Choon
author_facet Lau, Chin Shern
Aw, Tar Choon
author_sort Lau, Chin Shern
collection PubMed
description Although vaccine effectiveness reports are essential to assessing policies on SARS-CoV-2 vaccination, several factors can affect our interpretation of the results. These include the waning of antibodies, the prevailing viral variants at the time of the study, and COVID-19 disease prevalence in the population. Disease prevalence significantly impacts absolute risk reduction and could skew expected efficacy when increased disease prevalence inflates the absolute risk reduction in the face of a constant relative risk reduction. These factors must be considered in the interpretation of vaccine effectiveness to better understand how vaccines can improve disease prevention among the population. We highlight the impact of various factors on vaccine effectiveness.
format Online
Article
Text
id pubmed-9864852
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98648522023-01-22 Considerations in Understanding Vaccine Effectiveness Lau, Chin Shern Aw, Tar Choon Vaccines (Basel) Commentary Although vaccine effectiveness reports are essential to assessing policies on SARS-CoV-2 vaccination, several factors can affect our interpretation of the results. These include the waning of antibodies, the prevailing viral variants at the time of the study, and COVID-19 disease prevalence in the population. Disease prevalence significantly impacts absolute risk reduction and could skew expected efficacy when increased disease prevalence inflates the absolute risk reduction in the face of a constant relative risk reduction. These factors must be considered in the interpretation of vaccine effectiveness to better understand how vaccines can improve disease prevention among the population. We highlight the impact of various factors on vaccine effectiveness. MDPI 2022-12-22 /pmc/articles/PMC9864852/ /pubmed/36679865 http://dx.doi.org/10.3390/vaccines11010020 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Commentary
Lau, Chin Shern
Aw, Tar Choon
Considerations in Understanding Vaccine Effectiveness
title Considerations in Understanding Vaccine Effectiveness
title_full Considerations in Understanding Vaccine Effectiveness
title_fullStr Considerations in Understanding Vaccine Effectiveness
title_full_unstemmed Considerations in Understanding Vaccine Effectiveness
title_short Considerations in Understanding Vaccine Effectiveness
title_sort considerations in understanding vaccine effectiveness
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864852/
https://www.ncbi.nlm.nih.gov/pubmed/36679865
http://dx.doi.org/10.3390/vaccines11010020
work_keys_str_mv AT lauchinshern considerationsinunderstandingvaccineeffectiveness
AT awtarchoon considerationsinunderstandingvaccineeffectiveness